NCT01282528 Ultrasonographic Monitoring of Response to Infliximab in Patients With Rheumatoid Arthritis Status UNKNOWN Phase PHASE4
NCT01282372 Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab Status COMPLETED Phase N/A
NCT01282255 Efficacy of NNC109-0012 in Subjects With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT01277328 An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Status TERMINATED Phase N/A
NCT01274910 Effect of Fish Oil on Surgery Pain After Knee Replacement Patients: Randomized, Prospective, Double Blind, Placebo Control Trial Status UNKNOWN Phase NA
NCT01274182 GP2013 in the Treatment of RA Patients Refractory to or Intolerant of Standard Therapy Status COMPLETED Phase PHASE1/PHASE2
NCT01273519 Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab Status COMPLETED Phase N/A
NCT01272908 A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET) Status COMPLETED Phase PHASE3
NCT01270997 Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients Status COMPLETED Phase PHASE3
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study. Status COMPLETED Phase PHASE4
NCT01270035 Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate Status UNKNOWN Phase PHASE4
NCT01264770 Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA) Status TERMINATED Phase PHASE2
NCT01264211 Safety and Efficacy of the Combination of Diacerein 100 mg Daily and MTX Versus MTX Alone in the Treatment of Early Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01262118 Effects Of CP-690,550 (Tasocitinib) On Cholesterol Metabolism In Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01261403 Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01256736 To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01255761 A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects Status COMPLETED Phase PHASE4
NCT01254331 An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment Status COMPLETED Phase PHASE3